Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity CHRS - Coherus BioSciences, Inc.
630 M
LAST VALUE
-3.73%
2 YEAR CAGR
44.64%
5 YEAR CAGR
29.50%
10 YEAR CAGR